Glyn Truscott, Elkington + Fife

6 December 2017Big Pharma

LSPN Europe 2017: Challenges around the unitary SPC

Panellists at the Life Sciences Patent Network Europe (LSPN) conference in London today discussed the challenges around a potential unitary supplementary protection certificate (SPC).

Already registered?

Login to your account

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More features

‘We created law’: G1/24 and the creation of the ‘diamond standard’

BMS unit loses cell therapy patent at European Patent Office

Amgen sues Biocon over blockbuster bone drugs as first biosimilars enter market

Lord Justice Birss to become chancellor of the High Court

Bankruptcy judge approves $305m sale of genetics testing company

Sanofi successfully challenges rare disease patent in Europe

Bayer appoints new head of IP

WATCH: Policy direction—where are we now?